Chinese pharmaceutical firms are plunging as a drug safety scandal spills over to become a sector-wide trust crisis. July 23, 2018July 23, 2018 by IWB Facebook0 Twitter Email RSS feed - Syndicate IWB Subscribe To Our NewsletterAuthorities found Changsheng Biotechnology’s subsidiary produced substandard vaccines and forged production data. Its shares have been suspended from trading. 614 views
